Pershing Square proposes a slate of independent directors for Allergan

|About: Allergan plc (AGN)|By:, SA News Editor

Bill Ackman's Pershing Square Capital Management just happens to have a list of six BOD candidates that it believes would be a superb fit at Allergan (AGN -1.5%) just in case shareholders vote to replace six incumbent board members at the special meeting it is attempting to schedule.

Four of the six are institutional investors. I wonder how they would vote on Valeant's (VRX -2%) offer?